Every open market buy and sale of Immunovant, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net buyers over the last 12 months: $350M bought and $16.6M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when IMVT insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an IMVT officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every IMVT insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Atul PandeDirector | Sale plan | 3,000 | $36.00 | $108K | 116,731 | Nov 12Form 4 |
| Oct 28, 2026 | Tiago GiraoCFO | Sale | 6,606 | $28.50 | $188K | 234,192 | Oct 30Form 4 |
| Oct 21, 2026 | Jay S StoutChief Technology Officer | Sale | 2,595 | $28.94 | $75K | 198,937 | Oct 23Form 4 |
| Oct 7, 2026 | Jay S StoutChief Technology Officer | Sale | 3,809 | $32.06 | $122K | 201,532 | Oct 9Form 4 |
| Oct 7, 2026 | Melanie GloriaCOO | Sale | 2,241 | $32.06 | $72K | 217,060 | Oct 9Form 4 |
| Oct 7, 2026 | Tuyl Christopher VanChief Legal Officer | Sale | 1,327 | $32.06 | $43K | 175,218 | Oct 9Form 4 |
| Oct 2, 2026 | Eric VenkerCEO | Sale | 3,506 | $34.11 | $120K | 257,075 | Oct 5Form 4 |
| Sep 23, 2026 | Tuyl Christopher VanChief Legal Officer | Sale | 2,846 | $36.36 | $103K | 176,545 | Sep 25Form 4 |
| Aug 28, 2026 | Atul PandeDirector | Sale plan | 1,500 | $43.27 | $65K | 116,731 | Aug 28Form 4 |
| Aug 20, 2026 | Melanie GloriaCOO | Sale | 3,056 | $44.16 | $135K | 219,301 | Aug 21Form 4 |
| Jul 24, 2026 | Atul PandeDirector | Sale plan | 1,500 | $39.80 | $60K | 116,731 | Jul 24Form 4 |
| Jul 23, 2026 | Tiago GiraoCFO | Sale | 6,798 | $38.69 | $263K | 240,798 | Jul 24Form 4 |
| Jul 23, 2026 | Jay S StoutChief Technology Officer | Sale | 2,857 | $38.69 | $111K | 205,341 | Jul 24Form 4 |
| Jul 8, 2026 | Jay S StoutChief Technology Officer | Sale | 3,487 | $39.55 | $138K | 208,198 | Jul 10Form 4 |
| Jul 8, 2026 | Tuyl Christopher VanChief Legal Officer | Sale | 1,206 | $39.55 | $48K | 179,391 | Jul 10Form 4 |
IMVT insider trading FAQ
Are IMVT insiders buying or selling?
Insiders are net buyers over the last 12 months. 1 insiders bought $350M of IMVT on the open market in 1 trades, and 9 sold $16.6M in 42 trades, 9% of that under pre-arranged trading plans.
When did an IMVT insider last buy shares?
Roivant Sciences Ltd. (Director) bought 16,666,666 shares for $350M on Dec 12, 2025, reported on Dec 12, 2025.
When did an IMVT insider last sell shares?
Atul Pande (Director) sold 3,000 shares for $108K on Nov 11, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
